{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T20:40:30Z","timestamp":1722890430949},"reference-count":13,"publisher":"Cambridge University Press (CUP)","issue":"1","license":[{"start":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T00:00:00Z","timestamp":1242345600000},"content-version":"unspecified","delay-in-days":7043,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["journals.cambridge.org"],"crossmark-restriction":true},"short-container-title":["Epidemiol. Infect."],"published-print":{"date-parts":[[1990,2]]},"abstract":"<jats:title>SUMMARY<\/jats:title><jats:p>The relative contribution of various risk factors to the incidence of acute hepatitis B in Italy was estimated using a special surveillance system (SEIEVA) for type-specific acute viral hepatitis. At present 146 health departments (USLs) which contain 21% of the Italian population participate in SEIEVA out of the total of 650. Data on 2460 hepatitis B cases and 708 hepatitis A cases were compared.<\/jats:p><jats:p>Hospitalization, surgical intervention, dental therapy, other percutaneous exposures, barber shop shaving, i.v. drug abuse and household contact with HBsAg carriers were associated with acute hepatitis B and a large number of cases were attributable to these risk factors.<\/jats:p><jats:p>Because the control programme based on vaccination will not be effective in the short term at reducing hepatitis B incidence, other additional interventions are recommended.<\/jats:p>","DOI":"10.1017\/s0950268800054613","type":"journal-article","created":{"date-parts":[[2009,5,15]],"date-time":"2009-05-15T09:23:11Z","timestamp":1242379391000},"page":"135-141","update-policy":"http:\/\/dx.doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":12,"title":["Prevention of hepatitis B in Italy: lessons from surveillance of type-specific acute viral hepatitis"],"prefix":"10.1017","volume":"104","author":[{"given":"A.","family":"Mele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. A.","family":"Stazi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"O. N.","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Pasquini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"name":"Seieva Collaborating Group","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"56","published-online":{"date-parts":[[2009,5,15]]},"reference":[{"key":"S0950268800054613_ref006","first-page":"43","volume-title":"Monographs in Epidemiology and Biostatistics","author":"Schlesselman","year":"1982"},{"key":"S0950268800054613_ref004","unstructured":"4. Mele A , , SEIEVA. Sistema Epidemiologico Integrato dell'epatite Virale Acuta. Rapporto Annuale 1987. Roma, Istituto Superiore di Sanit\u00e0, Rapporto no. 13. 1988."},{"key":"S0950268800054613_ref002","doi-asserted-by":"publisher","DOI":"10.1007\/BF00419494"},{"key":"S0950268800054613_ref001","first-page":"235","article-title":"Epidemiology of hepatitis B in Italy","volume":"24","author":"Dardanoni","year":"1988","journal-title":"Annali dell'istituto Superiore di Sanit\u00e0"},{"key":"S0950268800054613_ref013","doi-asserted-by":"publisher","DOI":"10.1007\/BF00145067"},{"key":"S0950268800054613_ref008","first-page":"24","volume-title":"Annuario di Statistica Sanitaria","volume":"XXV","year":"1980"},{"key":"S0950268800054613_ref011","first-page":"123","article-title":"Distribuzione degli anticorpi anti-HAV nel personale di due ospedali della regione Lazio","volume":"24","author":"Pasquini","year":"1982","journal-title":"Annali Sclavo"},{"key":"S0950268800054613_ref007","first-page":"28","volume-title":"Annuario di Statistica Sanitaria","volume":"XXV","year":"1980"},{"key":"S0950268800054613_ref010","unstructured":"10. Avico U , , L'uso degli indicatori nell\u013eepidemiologia delle tossicodipendenze in Italia. Roma, Istituto Superiore di Sanit\u00e0, Rapporto no. 8. 1987."},{"key":"S0950268800054613_ref005","doi-asserted-by":"publisher","DOI":"10.1016\/0264-410X(89)90056-X"},{"key":"S0950268800054613_ref012","first-page":"523","article-title":"Prevalence of antibody to hepatitis A virus in Healthy individuals of Milan","volume":"57","author":"Zanetti","year":"1978","journal-title":"Bollettino dell\u013eIstituto Sieroterapico Milanese"},{"key":"S0950268800054613_ref009","first-page":"27","volume-title":"Statistiche Sanitarie","volume":"XXVII","year":"1986"},{"key":"S0950268800054613_ref003","first-page":"284","article-title":"L'epatite virale acuta in Italia: risultati 1986 del Sistema Epidemiologico Integrato di Sorveglianza (SEIEVA)","volume":"88","author":"Mele","journal-title":"L'Igiene Moderna 1987"}],"container-title":["Epidemiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0950268800054613","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,18]],"date-time":"2019-05-18T22:02:51Z","timestamp":1558216971000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0950268800054613\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1990,2]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1990,2]]}},"alternative-id":["S0950268800054613"],"URL":"https:\/\/doi.org\/10.1017\/s0950268800054613","relation":{},"ISSN":["0950-2688","1469-4409"],"issn-type":[{"type":"print","value":"0950-2688"},{"type":"electronic","value":"1469-4409"}],"subject":[],"published":{"date-parts":[[1990,2]]},"assertion":[{"value":"Cambridge University Press 1990","name":"license","label":"License","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}